e-Drug3D

1601

PICOSULFATE


INN
PICOSULFATE

(has an active metabolite)

cas 10040-45-6
CLASS

METABOLISM
LAXATIVE
HYDROLYZED BY COLONIC BACTERIA
STIMULATE COLONIC PERISTALSIS

ROUTE (list)

ORAL

ATC code

A06AB08
A06AB58

PK parameters

Tmax 7 HOUR
t1/2 7.4 HOUR

Target

-

DrugCentral

Unknown

Download SDF file Phenol, 4,4'-(2-pyridinylmethylene)bis-, 1,1'-bis(hydrogen sulfate), sodium salt (1:2)

Formula:
C18H15NO8S2

Calculated chemical properties:

MW 437.45
NB_atoms 29
XLogP 2.63
PSA 140.107
NB_HD 2
NB_HA 9
fsp3 0.06
Lipinski(0=no;1=yes) 0

FDA
NDA 202535 (label) INN (CITRIC ACID ; MAGNESIUM OXIDE ; SODIUM PICOSULFATE) PREPOPIK (FERRING PHARMS INC) APPROVAL= AP YEAR= 2012 NEWMOLECULARENTITY DISCONTINUED
NDA 205743 (pdf not found) INN (CITRIC ACID ; MAGNESIUM OXIDE ; SODIUM PICOSULFATE) CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE (PAR PHARM INC) APPROVAL= TA YEAR= 2016
NDA 209589 (label) INN (CITRIC ACID ; MAGNESIUM OXIDE ; SODIUM PICOSULFATE) CLENPIQ (FERRING PHARMS INC) APPROVAL= AP YEAR= 2017
NDA 212789 (pdf not found) INN (CITRIC ACID ; MAGNESIUM OXIDE ; SODIUM PICOSULFATE) SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID (HETERO LABS LTD V) APPROVAL= AP YEAR= 2022

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL